Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1998 Jul;57(7):422–424. doi: 10.1136/ard.57.7.422

Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia

P Cacoub 1, N Boukli 1, P Hausfater 1, A Garbarg-Chenon 1, P Ghillani 1, V Thibault 1, L Musset 1, J M Huraux 1, J Piette 1
PMCID: PMC1752657  PMID: 9797569

Abstract

BACKGROUND—Infection with human parvovirus B19 (B19) has been reported in a few patients with various vasculitis syndromes. Mixed cryoglobulinaemia (MC), a model of small vessel size vasculitis, may result from numerous infectious diseases, particularly hepatitis C virus (HCV) infection.
AIM—To assess the prevalence of seric B19 infection markers in a large series of patients with MC, with or without HCV infection.
PATIENTS AND METHODS—Sixty four patients were studied: essential MC (EMC, n = 19), MC associated with non-infectious diseases (non-essential MC, n = 9), and patients with HCV infection with (HCV-MC, n = 18) or without MC (HCV-no-MC, n = 18). Patients were considered to have MC if two successive determinations of their serum cryoglobulin concentration were above 0.05 g/l. Serum samples were analysed for specific IgG and IgM antibodies to B19 by enzyme immunoassay. B19 DNA detection was performed by polymerase chain reaction using a set of primers located in the VP1 gene, separately in serum and in cryoprecipitates to investigate a possible capture of B19 DNA in cryoprecipitate. The study also looked for a possible enrichment for of IgG antibodies to B19 in MC.
RESULTS—The presence of specific IgG antibodies to B19 was found in 68% EMC, 56% non-essential MC, 78% HCV-MC, and 78% HCV-no-MC. No patient of either group had specific IgM antibodies to B19, or B19 DNA in serum or in cryoprecipitate. Overall, IgG antibodies to B19 were found in 46 of 64 (72%) serum samples, a prevalence quite similar to the prevalence in general adult population (> 60 %). A specific enrichment of IgG antibodies to B19 in the MC was not found.
CONCLUSION—These results suggest that B19 infection is neither an aetiological factor of EMC, nor a cofactor that may lead to MC production in patients with chronic HCV infection.

 Keywords: mixed cryoglobulinaemia; parvovirus B19; hepatitis C virus

Full Text

The Full Text of this article is available as a PDF (89.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Chung R. T., Kaplan L. M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992 Nov 19;327(21):1490–1495. doi: 10.1056/NEJM199211193272104. [DOI] [PubMed] [Google Scholar]
  2. Bonomo L., Dammacco F. Immune complex cryoglobulinaemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. Clin Exp Immunol. 1971 Aug;9(2):175–181. [PMC free article] [PubMed] [Google Scholar]
  3. Brouet J. C., Clauvel J. P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974 Nov;57(5):775–788. doi: 10.1016/0002-9343(74)90852-3. [DOI] [PubMed] [Google Scholar]
  4. Cacoub P., Fabiani F. L., Musset L., Perrin M., Frangeul L., Leger J. M., Huraux J. M., Piette J. C., Godeau P. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994 Feb;96(2):124–132. doi: 10.1016/0002-9343(94)90132-5. [DOI] [PubMed] [Google Scholar]
  5. Cacoub P., Lunel F., Musset L., Opolon P., Piette J. C. Hepatitis C virus and cryoglobulinemia. N Engl J Med. 1993 Apr 15;328(15):1121–1124. [PubMed] [Google Scholar]
  6. Capra J. D., Winchester R. J., Kunkel H. G. Cold-reactive rheumatoid factors in infectious mononucleosis and other diseases. Arthritis Rheum. 1969 Apr;12(2):67–73. doi: 10.1002/art.1780120202. [DOI] [PubMed] [Google Scholar]
  7. Cohen B. J., Buckley M. M., Clewley J. P., Jones V. E., Puttick A. H., Jacoby R. K. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis. 1986 Oct;45(10):832–838. doi: 10.1136/ard.45.10.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cohen B. J., Buckley M. M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988 Feb;25(2):151–153. doi: 10.1099/00222615-25-2-151. [DOI] [PubMed] [Google Scholar]
  9. Cohen B. J. Human parvovirus B19 infection in Kawasaki disease. Lancet. 1994 Jul 2;344(8914):59–59. [PubMed] [Google Scholar]
  10. Corman L. C., Dolson D. J. Polyarteritis nodosa and parvovirus B19 infection. Lancet. 1992 Feb 22;339(8791):491–491. doi: 10.1016/0140-6736(92)91096-q. [DOI] [PubMed] [Google Scholar]
  11. Courouce A. M., Ferchal F., Morinet F., Muller A., Drouet J., Soulier J. P., Perol Y. Human parvovirus infections in France. Lancet. 1984 Jan 21;1(8369):160–160. doi: 10.1016/s0140-6736(84)90086-2. [DOI] [PubMed] [Google Scholar]
  12. Ferri C., Greco F., Longombardo G., Palla P., Moretti A., Marzo E., Fosella P. V., Pasero G., Bombardieri S. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991 Dec;34(12):1606–1610. doi: 10.1002/art.1780341221. [DOI] [PubMed] [Google Scholar]
  13. Finkel T. H., Török T. J., Ferguson P. J., Durigon E. L., Zaki S. R., Leung D. Y., Harbeck R. J., Gelfand E. W., Saulsbury F. T., Hollister J. R. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet. 1994 May 21;343(8908):1255–1258. doi: 10.1016/s0140-6736(94)92152-0. [DOI] [PubMed] [Google Scholar]
  14. Fiorini G., Bernasconi P., Sinico R. A., Chianese R., Pozzi F., D'Amico G. Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia. Clin Exp Immunol. 1986 Apr;64(1):65–70. [PMC free article] [PubMed] [Google Scholar]
  15. Gorevic P. D., Kassab H. J., Levo Y., Kohn R., Meltzer M., Prose P., Franklin E. C. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980 Aug;69(2):287–308. doi: 10.1016/0002-9343(80)90390-3. [DOI] [PubMed] [Google Scholar]
  16. Hurwitz D., Quismorio F. P., Friou G. J. Cryoglobulinaemia in patients with infectious endocarditis. Clin Exp Immunol. 1975 Jan;19(1):131–141. [PMC free article] [PubMed] [Google Scholar]
  17. Joseph P. R. Fifth disease: the frequency of joint involvement in adults. N Y State J Med. 1986 Nov;86(11):560–563. [PubMed] [Google Scholar]
  18. Kantor G. L., Goldberg L. S., Johnson B. L., Jr, Derechin M. M., Barnett E. V. Immunologic abnormalities induced by postperfusion cytomegalovirus infection. Ann Intern Med. 1970 Oct;73(4):553–558. doi: 10.7326/0003-4819-73-4-553. [DOI] [PubMed] [Google Scholar]
  19. Kawasaki H., Kretsinger R. H. Calcium-binding proteins. 1: EF-hands. Protein Profile. 1994;1(4):343–517. [PubMed] [Google Scholar]
  20. Leruez-Ville M., Laugé A., Morinet F., Guillevin L., Dény P. Polyarteritis nodosa and parvovirus B19. Lancet. 1994 Jul 23;344(8917):263–264. doi: 10.1016/s0140-6736(94)93030-9. [DOI] [PubMed] [Google Scholar]
  21. Levo Y., Gorevic P. D., Kassab H. J., Zucker-Franklin D., Franklin E. C. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med. 1977 Jun 30;296(26):1501–1504. doi: 10.1056/NEJM197706302962605. [DOI] [PubMed] [Google Scholar]
  22. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., Grippon P., Hoang C., Valla D., Piette J. C. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994 May;106(5):1291–1300. doi: 10.1016/0016-5085(94)90022-1. [DOI] [PubMed] [Google Scholar]
  23. Meltzer M., Franklin E. C., Elias K., McCluskey R. T., Cooper N. Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966 Jun;40(6):837–856. doi: 10.1016/0002-9343(66)90200-2. [DOI] [PubMed] [Google Scholar]
  24. Musset L., Diemert M. C., Taibi F., Thi Huong Du L., Cacoub P., Leger J. M., Boissy G., Gaillard O., Galli J. Characterization of cryoglobulins by immunoblotting. Clin Chem. 1992 Jun;38(6):798–802. [PubMed] [Google Scholar]
  25. Naides S. J., Scharosch L. L., Foto F., Howard E. J. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum. 1990 Sep;33(9):1297–1309. doi: 10.1002/art.1780330901. [DOI] [PubMed] [Google Scholar]
  26. Nigro G., Zerbini M., Krzysztofiak A., Gentilomi G., Porcaro M. A., Mango T., Musiani M. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet. 1994 May 21;343(8908):1260–1261. doi: 10.1016/s0140-6736(94)92154-7. [DOI] [PubMed] [Google Scholar]
  27. Pawlotsky J. M., Ben Yahia M., Andre C., Voisin M. C., Intrator L., Roudot-Thoraval F., Deforges L., Duvoux C., Zafrani E. S., Duval J. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994 Apr;19(4):841–848. [PubMed] [Google Scholar]
  28. Steere A. C., Hardin J. A., Ruddy S., Mummaw J. G., Malawista S. E. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum. 1979 May;22(5):471–483. doi: 10.1002/art.1780220506. [DOI] [PubMed] [Google Scholar]
  29. Tyndall A., Jelk W., Hirsch H. H. Parvovirus B19 and erosive polyarthritis. Lancet. 1994 Feb 19;343(8895):480–481. doi: 10.1016/s0140-6736(94)92725-1. [DOI] [PubMed] [Google Scholar]
  30. Yoto Y., Kudoh T., Haseyama K., Suzuki N., Chiba S., Matsunaga Y. Human parvovirus B19 infection in Kawasaki disease. Lancet. 1994 Jul 2;344(8914):58–59. doi: 10.1016/s0140-6736(94)91080-4. [DOI] [PubMed] [Google Scholar]
  31. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988 Apr;25(2):159–172. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES